Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma

References

1. 1.↵
   1. Goel R,
   2. Moore W,
   3. Sumer B, et al

   . Clinical practice in PET/CT for the management of head and neck squamous cell cancer. AJR Am J Roentgenol 2017;209:289–303 doi:10.2214/AJR.17.18301 pmid:28731808

   CrossRefPubMed
2. 2.
   1. Tantiwongkosi B,
   2. Yu F,
   3. Kanard A, et al

   . Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma. World J Radiol 2014;6:177–91 doi:10.4329/wjr.v6.i5.177 pmid:24876922

   CrossRefPubMed
3. 3.↵
   1. Kale H,
   2. Rath TJ

   . Chapter 3: the role of PET/CT in squamous cell carcinoma of the head and neck. Semin Ultrasound CT MR 2017;38:479–94 doi:10.1053/j.sult.2017.06.001 pmid:29031365

   CrossRefPubMed
4. 4.↵
   1. Mehanna H,
   2. Wong WL,
   3. McConkey CC, et al

   ; PET-NECK Trial Management Group. PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 2016;374:1444–54 doi:10.1056/NEJMoa1514493 pmid:27007578

   CrossRefPubMed
5. 5.↵
   1. McDermott M,
   2. Hughes M,
   3. Rath T, et al

   . Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer. AJNR Am J Neuroradiol 2013;34:1632–36 doi:10.3174/ajnr.A3494 pmid:23639557

   Abstract/FREE Full Text
6. 6.↵
   1. Nayak JV,
   2. Walvekar RR,
   3. Andrade RS, et al

   . Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 2007;117:2129–34 doi:10.1097/MLG.0b013e318149e6bc pmid:17921898

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Aiken AH,
   2. Farley A,
   3. Baugnon KL, et al

   . Implementation of a novel surveillance template for head and neck cancer: Neck Imaging Reporting and Data System (NI-RADS). J Am Coll Radiol 2016;13:743–46 doi:10.1016/j.jacr.2015.09.032 pmid:26577876

   CrossRefPubMed
8. 8.
   1. Aiken AH,
   2. Hudgins PA

   . Neck Imaging Reporting and Data System. Magn Reson Imaging Clin N Am 2018;26:51–62 doi:10.1016/j.mric.2017.08.004 pmid:29128006

   CrossRefPubMed
9. 9.↵
   1. Aiken AH,
   2. Rath TJ,
   3. Anzai Y, et al

   . ACR Neck Imaging Reporting and Data Systems (NI-RADS): a white paper of the ACR NI-RADS Committee. J Am Coll Radiol 2018;15:1097–1108 doi:10.1016/j.jacr.2018.05.006 pmid:29983244

   CrossRefPubMed
10. 10.↵
    1. Wangaryattawanich P,
    2. Branstetter BFt,
    3. Hughes M, et al

    . Negative predictive value of NI-RADS category 2 in the first posttreatment FDG-PET/CT in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2018;39:1884–88 doi:10.3174/ajnr.A5767 pmid:30166429

    Abstract/FREE Full Text
11. 11.↵
    1. Edge SB,
    2. Byrd DR,
    3. Compton CC, et al

    . AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. 7th ed. Springer-Verlag 2010;53:39–126
12. 12.↵
    1. Krieger DA,
    2. Hudgins PA,
    3. Nayak GK, et al

    . Initial performance of NI-RADS to predict residual or recurrent head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2017;38:1193–99 doi:10.3174/ajnr.A5157 pmid:28364010

    Abstract/FREE Full Text
13. 13.↵
    1. Bird T,
    2. Barrington S,
    3. Thavaraj S, et al

    . (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging 2016;43:1239–47 doi:10.1007/s00259-015-3290-4 pmid:26707387

    CrossRefPubMed
14. 14.↵
    1. Purohit BS,
    2. Ailianou A,
    3. Dulguerov N, et al

    . FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging 2014;5:585–602 doi:10.1007/s13244-014-0349-x pmid:25154759

    CrossRefPubMed
15. 15.
    1. Rassekh CH,
    2. Cost JL,
    3. Hogg JP, et al

    . Positron emission tomography in Warthin’s tumor mimicking malignancy impacts the evaluation of head and neck patients. Am J Otolaryngol 2015;36:259–63 doi:10.1016/j.amjoto.2014.11.008 pmid:25523505

    CrossRefPubMed
16. 16.↵
    1. Schwarz E,
    2. Hurlimann S,
    3. Soyka JD, et al

    . FDG-positive Warthin’s tumors in cervical lymph nodes mimicking metastases in tongue cancer staging with PET/CT. Otolaryngol Head Neck Surg 2009;140:134–35 doi:10.1016/j.otohns.2008.09.019 pmid:19130980

    CrossRefPubMed
17. 17.↵
    1. Huang SH,
    2. O’Sullivan B

    . Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol 2017;18:40 doi:10.1007/s11864-017-0484-y pmid:28555375

    CrossRefPubMed
18. 18.↵
    1. Subramaniam RM,
    2. Alluri KC,
    3. Tahari AK, et al

    . PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm. J Nucl Med 2014;55:431–38 doi:10.2967/jnumed.113.125542 pmid:24408893

    Abstract/FREE Full Text
19. 19.↵
    1. Manca G,
    2. Vanzi E,
    3. Rubello D, et al

    . (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications. Eur J Nucl Med Mol Imaging 2016;43:1360–75 doi:10.1007/s00259-015-3294-0 pmid:26780912

    CrossRefPubMed
20. 20.↵
    1. de Langen AJ,
    2. Vincent A,
    3. Velasquez LM, et al

    . Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis. J Nucl Med 2012;53:701–08 doi:10.2967/jnumed.111.095299 pmid:22496583

    Abstract/FREE Full Text